Novo Nordisk stumbles against Eli Lilly in GLP-1 drug battle. Which stock is the best buy from here? (2025-11-24)
Eli Lilly's stock is soaring while Novo Nordisk is sinking. Why it makes sense to stick with the market winner, despite its rising valuation.